Skip to main content

FDA previsões e probabilidades

·
A FDA aprova o ONS-5010 da Outlook Therapeutics?

A FDA aprova o ONS-5010 da Outlook Therapeutics?

85%

$4.9K Vol.

$4.3K Liq.

Ends em 25 dias

A FDA aprova o adesivo semanal de baixa dose de estrogênio da Viatris?

A FDA aprova o adesivo semanal de baixa dose de estrogênio da Viatris?

88%

$1.7K Vol.

$3.3K Liq.

Ends em 27 dias

A FDA aprova o Retatrutide este ano?

A FDA aprova o Retatrutide este ano?

14%

$575K Vol.

$5.2K Liq.

3

Ends em 6 meses

Quem Trump anunciará como próximo comissário da FDA?

Quem Trump anunciará como próximo comissário da FDA?

27%

Kyle Diamantas

$13.7K Vol.

$32.9K Liq.

Ends em 6 meses

FDA aprova Sarclisa Subcutânea da Sanofi?

FDA aprova Sarclisa Subcutânea da Sanofi?

89%

$3.0K Vol.

$5.3K Liq.

Ends em 19 dias

A FDA move o BPC-157 para a Categoria 1 por...?

A FDA move o BPC-157 para a Categoria 1 por...?

32%

31 de agosto de 2026

$933 Vol.

$863 Liq.

Ends em 6 meses

A FDA aprova a Centanafadina da Otsuka?

A FDA aprova a Centanafadina da Otsuka?

66%

$75 Vol.

$118 Liq.

Ends em 20 dias

A FDA aprova o Daraxonrasib este ano?

A FDA aprova o Daraxonrasib este ano?

75%

$318 Vol.

$1.0K Liq.

Ends em 6 meses

FDA aprova transferência de tecnologia Arcalyst?

FDA aprova transferência de tecnologia Arcalyst?

11%

$5.7K Vol.

$267 Liq.

Ends há 15 dias

FDA approves Celcuity's Gedatolisib?

FDA approves Celcuity's Gedatolisib?

69%

$0 Vol.

$116 Liq.

Ends em 13 dias

A FDA aprova o Autoinjetor FUROSCIX ReadyFlow da MannKind?

A FDA aprova o Autoinjetor FUROSCIX ReadyFlow da MannKind?

64%

$176 Vol.

$80 Liq.

Ends em 22 dias

A FDA aprova o Atacicept da Vera Therapeutics?

A FDA aprova o Atacicept da Vera Therapeutics?

88%

$431 Vol.

$95 Liq.

Ends em 3 dias

FDA aprova Rivoceranibe + camrelizumabe da Elevar Therapeutics?

FDA aprova Rivoceranibe + camrelizumabe da Elevar Therapeutics?

59%

$20 Vol.

$80 Liq.

Ends em 19 dias

Hantavirus vaccine in 2026?

Hantavirus vaccine in 2026?

6%

$126K Vol.

$41.3K Liq.

7

Ends em 6 meses

Frequently Asked Questions

Polymarket is the world’s largest prediction market, where you can stay informed and profit from your knowledge by trading on things related to breaking news, politics, sports, elections, crypto, finance, tech, culture, including topics like FDA.

Polymarket currently hosts 14 active markets for FDA that lets you track or trade on predictions like “A FDA aprova o ONS-5010 da Outlook Therapeutics?”. Whether you are tracking widely debated events or niche outcomes, the platform aggregates real-time odds based on over $732K in trading volume, providing a comprehensive view of fan and investor sentiment.

Each polymarket is a yes/no question, like “Hantavirus vaccine in 2026? ”. You buy shares in “yes” or “no” outcomes. Prices reflect crowd-sourced odds and probabilities. For example, if yes is at 30 cents, that’s a 30% chance. Markets resolve based on official results. For multi-outcome events, like “Quem Trump anunciará como próximo comissário da FDA?,” you simply trade on the specific outcome you think will win.

As of today, the most active market is “A FDA aprova o Retatrutide este ano?,” where the crowd is currently assigning a 86% chance to No. These odds update in real-time as new information emerges and users trade, offering a dynamic snapshot of what the market believes will happen compared to traditional bookmaker odds.

It cuts through the noise. Unlike polls or punditry, Polymarket shows you real-time odds on FDA predictions backed by financial conviction that are often faster and more accurate than experts or surveys. You get an unbiased view of what thousands of traders think will actually happen, often more accurate than polls. Plus, you can trade shares and potentially profit if your predictions are spot on.